InsiderTrades

Form 4 for COR Cencora

Accepted 2024-04-17 00:00:00 ET · period of report 2024-04-15 · accession 0001140859-24-000062 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-04-17 2024-04-15 COR Mauch Robert P. EVP, COO M - OptEx $89.58 +33.9K 82.0K +70% +$3.03M
D 2024-04-17 2024-04-15 COR Mauch Robert P. EVP, COO S - Sale+OE $235.09 -57.6K 24.4K -70% -$13.53M
D 2024-04-17 2024-04-15 COR Mauch Robert P. EVP, COO M - OptEx $0.00 -33.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-04-15 M A 33,877 $89.58 81,976 D — —
2 Common Common Stock 2024-04-15 S D 57,564 $235.09 24,412 D — — (F1) The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 12/19/2023. (F2) The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $234.17 to $236.56, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
3 Derivative Non-qualified Stock Option (Right to Buy) 2024-04-15 M D 33,877 $0.00 0 D $89.58 · — to 2025-11-14 33,877 Common Stock (F3) Exercisable in four equal annual installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.